Pular para o conteúdo
Albinismo oculocutâneo sindrômico
ORPHA:284811DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
neuro

Albinismo que afeta os olhos e a pele, e faz parte de uma síndrome maior.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O albinismo oculocutâneo sindrômico é um tipo de albinismo que atinge os olhos e a pele, integrando um conjunto mais amplo de alterações em outros órgãos. As pessoas afetadas costumam apresentar visão reduzida, sangramentos excessivos após pequenos cortes ou exames, infecções de pele frequentes e atrasos no desenvolvimento. O diagnóstico pode ser investigado por avaliação médica e por centenas de testes genéticos especializados descritos na literatura. Esta condição não consta na lista oficial de PCDTs de doenças raras do Ministério da Saúde, não havendo tratamentos dispensados especificamente pelo SUS para ela.

📋
Informacoes curadas por IA — podem conter imprecisoes

Albinismo que afeta os olhos e a pele, e faz parte de uma síndrome maior.

Publicações científicas
2 artigos
Último publicado: 2022 Jun 16
Medicamentos
9 com registro
LETROZOL, IVEVI, SABINE

Tem tratamento?

✓ 9 medicamentos específicos desta doença (registro ANVISA, FDA ou SUS/CEAF)
Ver detalhes, fases e interações →
LETROZOLIVEVISABINEMAHILANOAZYLEF�MILEMOLLETHOZY
Mais 4 moléculas em estudo para esta doença.
🏥
SUS: Cobertura mínimaScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
33 sintomas
👁️
Olhos
32 sintomas
🩸
Sangue
20 sintomas
🧬
Pele e cabelo
20 sintomas
🫃
Digestivo
14 sintomas
😀
Face
11 sintomas

+ 108 sintomas em outras categorias

Características mais comuns

—
Atrofia da medula espinhal
—
Grânulos densos plaquetários reduzidos
—
Comprometimento cognitivo
—
Metrorragia
—
Grânulos neutrofílicos gigantes
—
Menometrorragia
282sintomas
Sem dados (282)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 282 características clínicas mais associadas, ordenadas por frequência.

Atrofia da medula espinhalAtrophy of the spinal cord
Grânulos densos plaquetários reduzidosReduced platelet dense granules
Comprometimento cognitivoCognitive impairment
MetrorragiaMetrorrhagia
Grânulos neutrofílicos gigantesGiant neutrophil granules

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa4desde 2022
Total histórico2PubMed
Últimos 10 anos2publicações
Pico20201 papers
Linha do tempo
2022Hoje · 2026
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

15 genes identificados com associação a esta condição.

HPS4BLOC-3 complex member HPS4Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 4

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
67.3 TPM
Cérebro - Hemisfério cerebelar
66.6 TPM
Testículo
44.7 TPM
Skin Sun Exposed Lower leg
40.8 TPM
Skin Not Sun Exposed Suprapubic
36.3 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 4Hermansky-Pudlak syndrome with pulmonary fibrosis
HGNC:15844UniProt:Q9NQG7
HPS1BLOC-3 complex member HPS1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 1

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
57.7 TPM
Cervix Endocervix
54.4 TPM
Cervix Ectocervix
48.5 TPM
Sangue
48.2 TPM
Útero
47.2 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 1Hermansky-Pudlak syndrome with pulmonary fibrosis
HGNC:5163UniProt:Q92902
DTNBP1DysbindinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 7

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
37.2 TPM
Artéria tibial
29.7 TPM
Aorta
25.4 TPM
Cólon sigmoide
24.0 TPM
Brain Frontal Cortex BA9
21.5 TPM
OUTRAS DOENÇAS (1)
Hermansky-Pudlak syndrome 7
HGNC:17328UniProt:Q96EV8
BLOC1S6Biogenesis of lysosome-related organelles complex 1 subunit 6Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 9

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 9Hermansky-Pudlak syndrome 7
HGNC:8549UniProt:Q9UL45
LYSTLysosomal-trafficking regulatorDisease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (3)
RUNX2 regulates osteoblast differentiationFormation of the anterior neural plateFormation of the posterior neural plate
MECANISMO DE DOENÇA

Chediak-Higashi syndrome

A rare autosomal recessive disorder characterized by hypopigmentation, severe immunologic deficiency, a bleeding tendency, neurologic abnormalities, abnormal intracellular transport to and from the lysosome, and giant inclusion bodies in a variety of cell types. Most patients die at an early age unless they receive an allogeneic hematopoietic stem cell transplant (SCT).

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
14.6 TPM
Cerebelo
14.6 TPM
Nervo tibial
12.8 TPM
Tecido adiposo
12.7 TPM
Skin Not Sun Exposed Suprapubic
12.2 TPM
OUTRAS DOENÇAS (2)
Chediak-Higashi syndromeattenuated Chédiak-Higashi syndrome
HGNC:1968UniProt:Q99698
MYO5AUnconventional myosin-VaDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (5)
Regulation of actin dynamics for phagocytic cup formationFCGR3A-mediated phagocytosisTranslocation of SLC2A4 (GLUT4) to the plasma membraneRegulation of MITF-M-dependent genes involved in pigmentationInsulin processing
MECANISMO DE DOENÇA

Griscelli syndrome 1

Rare autosomal recessive disorder that results in pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, silvery-gray hair and accumulation of melanosomes in melanocytes. GS1 patients show developmental delay, hypotonia and intellectual disability, without apparent immune abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
68.3 TPM
Cerebelo
59.0 TPM
Brain Frontal Cortex BA9
53.8 TPM
Córtex cerebral
36.2 TPM
Brain Anterior cingulate cortex BA24
33.8 TPM
OUTRAS DOENÇAS (3)
Griscelli syndrome type 1Griscelli syndrome type 3neuroectodermal melanolysosomal disease
HGNC:7602UniProt:Q9Y4I1
AP3D1AP-3 complex subunit delta-1Disease-causing germline mutation(s) inAltamente restrito
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 10

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. HPS10 patients manifest albinism, neutropenia, immunodeficiency, neurodevelopmental delay, generalized seizures, and impaired hearing.

OUTRAS DOENÇAS (3)
Hermansky-Pudlak syndrome 10ocular albinism with late-onset sensorineural deafnessX-linked recessive ocular albinism
HGNC:568UniProt:O14617
BLOC1S3Biogenesis of lysosome-related organelles complex 1 subunit 3Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 8

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 8Hermansky-Pudlak syndrome 7
HGNC:20914UniProt:Q6QNY0
HPS3BLOC-2 complex member HPS3Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 3

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
27.4 TPM
Linfócitos
24.4 TPM
Útero
22.8 TPM
Nervo tibial
21.4 TPM
Baço
18.9 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 3Hermansky-Pudlak syndrome without pulmonary fibrosis
HGNC:15597UniProt:Q969F9
HPS5BLOC-2 complex member HPS5Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 5

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
30.6 TPM
Testículo
25.4 TPM
Linfócitos
25.0 TPM
Fibroblastos
23.6 TPM
Aorta
20.7 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 5Hermansky-Pudlak syndrome without pulmonary fibrosis
HGNC:17022UniProt:Q9UPZ3
BLOC1S5Biogenesis of lysosome-related organelles complex 1 subunit 5Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 11

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 11Hermansky-Pudlak syndrome 7
HGNC:18561UniProt:Q8TDH9
HPS6BLOC-2 complex member HPS6Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 6

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
30.4 TPM
Linfócitos
26.4 TPM
Fallopian Tube
19.4 TPM
Útero
18.1 TPM
Baço
17.0 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 6Hermansky-Pudlak syndrome without pulmonary fibrosis
HGNC:18817UniProt:Q86YV9
AP3B1AP-3 complex subunit beta-1Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 2

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. HPS2 differs from the other forms of HPS in that it includes immunodeficiency in its phenotype and patients with HPS2 have an increased susceptibility to infections.

OUTRAS DOENÇAS (1)
Hermansky-Pudlak syndrome 2
HGNC:566UniProt:O00203
RAB27ARas-related protein Rab-27ADisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
RAB geranylgeranylationInsulin processing
MECANISMO DE DOENÇA

Griscelli syndrome 2

Rare autosomal recessive disorder that results in pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes. GS2 patients also develop an uncontrolled T-lymphocyte and macrophage activation syndrome, known as hemophagocytic syndrome, leading to death in the absence of bone marrow transplantation. Neurological impairment is present in some patients, likely as a result of hemophagocytic syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
45.3 TPM
Pituitária
44.8 TPM
Pulmão
38.4 TPM
Próstata
31.2 TPM
Aorta
29.4 TPM
OUTRAS DOENÇAS (1)
Griscelli syndrome type 2
HGNC:9766UniProt:P51159
MLPHMelanophilinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Regulation of MITF-M-dependent genes involved in pigmentation
MECANISMO DE DOENÇA

Griscelli syndrome 3

Rare autosomal recessive disorder characterized by pigmentary dilution of the skin and hair, the presence of large clumps of pigment in hair shafts, and an accumulation of melanosomes in melanocytes, without other clinical manifestations.

EXPRESSÃO TECIDUAL(Ubíquo)
Próstata
139.8 TPM
Glândula salivar
132.9 TPM
Cervix Ectocervix
114.9 TPM
Cervix Endocervix
82.7 TPM
Estômago
72.1 TPM
OUTRAS DOENÇAS (1)
Griscelli syndrome type 3
HGNC:29643UniProt:Q9BV36

Medicamentos e terapias

SORAFENIBPhase 2

Mecanismo: Vascular endothelial growth factor receptor inhibitor

BOSENTANPhase 2

Mecanismo: Endothelin receptor, ET-A/ET-B antagonist

LETROZOLEPhase 2

Mecanismo: Cytochrome P450 19A1 inhibitor

PENTOXIFYLLINEPhase 1

Mecanismo: 3',5'-cyclic phosphodiesterase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

906 variantes patogênicas registradas no ClinVar.

🧬 HPS4: NM_022081.6(HPS4):c.1462C>T (p.Gln488Ter) ()
🧬 HPS4: NM_022081.6(HPS4):c.1714-5_1732del ()
🧬 HPS4: NM_022081.6(HPS4):c.502-9C>A ()
🧬 HPS4: NM_022081.6(HPS4):c.583C>T (p.Leu195Phe) ()
🧬 HPS4: NM_022081.6(HPS4):c.1693_1694del (p.Ser565fs) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 23
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 4 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Albinismo oculocutâneo sindrômico

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
2 papers (10 anos)
#1

Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.

Genes2022 Jun 16

Oculocutaneous albinism (OCA) is an autosomal recessive syndromic and non-syndromic defect with deficient or a complete lack of the melanin pigment. The characteristics of OCA appears in skin, hair, and eyes with variable degree of pigmentation. Clinical manifestations of OCA include nystagmus, photophobia, reduced visual acuity, hypo-plastic macula, and iris trans-illumination. There are eight OCA types (OCA1-8) documented with non-syndromic characteristics. Molecular studies identified seven genes linked to the OCA phenotype (TYR, OCA2, TYRP1, SLC45A2, SLC24A5, C10orf11, and DCT) and one locus (OCA5) in consanguineous and sporadic albinism. The complications of OCA result in skin cancer and variable syndromes such as Hermansky-Pudlak syndrome (HPS) Chediak-Higashi syndrome (CHS). In the Pakistani population, autosomal recessive non-syndromic OCA is common and is associated with a large number of consanguineous families, and mutations in genes of non-syndromic types are reported. This review highlights the updates on the genetic mutation of OCA genes reported from Pakistani families. Several studies reported the genetic mutations in OCA1, OCA2, OCA3, OCA4, and OCA6 albinism in Pakistani families. A locus, OCA5, was also reported from the Pakistani population, but the gene has not been identified. A new type of OCA8 was identified due to the DCT gene mutation, and it is also reviewed here.

#2

Identification and Computational Analysis of Novel TYR and SLC45A2 Gene Mutations in Pakistani Families With Identical Non-syndromic Oculocutaneous Albinism.

Frontiers in genetics2020

Non-syndromic oculocutaneous albinism (nsOCA) is an inherited disorder of melanin biosynthesis with autosomal recessive mode of inheritance, presenting either hypopigmented or depigmented skin, hair, and eyes. It is genetically heterogeneous with seven loci (OCA1-OCA7) reported to date. In the present study, we have reported three consanguineous families (A, B, C) presenting identical nsOCA phenotypes. Sanger sequencing revealed a novel [NM_000372.5: c.826 T > C, p.(Cys276Arg)] and a recurrent variant [NM_000372.5: c.832C > T, p.(Arg278∗)] in tyrosinase (TYR) in families A and B, respectively. Microsatellite marker-based homozygosity mapping linked family C to OCA4. Sequence analysis identified a novel insertion variant (NM_016180.5: c.1331_1332insA) in the SLC45A2. Further, in silico mutagenesis and dynamic simulation approaches revealed that a novel Cys276Arg variant abolished the cysteine bridge and might contribute toward decreased stability of the TYR protein. Our study expands the mutation spectrum of the TYR and SLC45A2 genes and emphasizes that molecular investigations are essential for accurate disease diagnosis.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Albinismo oculocutâneo sindrômico.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Albinismo oculocutâneo sindrômico e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É um albinismo que acomete os olhos e a pele, fazendo parte de uma síndrome clínica mais extensa. Ele pode envolver disfunções em células do sangue, no sistema imune e no sistema nervoso.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

2 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:284811
    Orphanet
  2. GARD:21125
    GARD (NIH)
  3. Q55786973
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Albinismo oculocutâneo sindrômico. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/albinismo-oculocutaneo-sindromico

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Albinismo oculocutâneo sindrômico

ORPHA:284811 · MONDO:0017305
Medicamentos
4 registrados
MedGen
UMLS
C5681016
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara